2 hours Clearside Biomedical (NASDAQ:CLSD) Files 8-K with the SEC Regarding Latest Developments MarketBeat
Clearside Biomedical, a biopharmaceutical company dedicated to developing treatments for blinding eye diseases, recently submitted an 8-K form to the U.S. Securities and Exchange Commission (SEC), highlighting essential updates. The filing showcased si…
Nasdaq 100 · SEC · U.S.